|
PPM1D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.029300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25859999591904E-08 |
| Normal-vs-Stage2 |
1.390960E-01 |
| Normal-vs-Stage3 |
7.941800E-01 |
| Normal-vs-Stage4 |
1.916840E-01 |
| Stage1-vs-Stage2 |
6.827900E-02 |
| Stage1-vs-Stage3 |
6.12699999624766E-08 |
| Stage1-vs-Stage4 |
5.15479992024837E-10 |
| Stage2-vs-Stage3 |
1.831440E-01 |
| Stage2-vs-Stage4 |
2.669600E-02 |
| Stage3-vs-Stage4 |
1.230800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.832100E-04 |
| Normal-vs-AfricanAmerican |
1.716430E-01 |
| Normal-vs-Asian |
4.136600E-01 |
| Caucasian-vs-AfricanAmerican |
8.577200E-01 |
| Caucasian-vs-Asian |
9.850600E-01 |
| AfricanAmerican-vs-Asian |
9.546800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.269700E-02 |
| Normal-vs-Female |
1.803600E-04 |
| Male-vs-Female |
4.692300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.739410E-01 |
| Normal-vs-Age(41-60Yrs) |
2.246700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.649560E-02 |
| Normal-vs-Age(81-100Yrs) |
9.207200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.489600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.306200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.469400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.062200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.594610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.195400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.996200E-04 |
| Normal-vs-Grade 2 |
1.81970000179277E-08 |
| Normal-vs-Grade 3 |
1.080180E-01 |
| Normal-vs-Grade 4 |
2.819700E-02 |
| Grade 1-vs-Grade 2 |
4.340800E-03 |
| Grade 1-vs-Grade 3 |
1.241990E-04 |
| Grade 1-vs-Grade 4 |
6.20850004739992E-09 |
| Grade 2-vs-Grade 3 |
1.622780E-04 |
| Grade 2-vs-Grade 4 |
3.59340002198394E-10 |
| Grade 3-vs-Grade 4 |
6.173700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.72823993899374E-12 |
| Normal-vs-ccB subtype |
4.858600E-01 |
| ccA subtype-vs-ccB subtype |
4.39409999497542E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.201820E-02 |
| Normal-vs-N1 |
1.788590E-01 |
| N0-vs-N1 |
6.517900E-02 |
|
|
